$ADPT

3 theses
bullish 0%neutral 0%bearish 100%
Avg return (1y)
—
Win rate (1y)
— (0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 2, 4:30 PM ET
$ADPTSEC Form 4bearish
Sold 30,664 @ $24.40 avg · $748,208 · 2026-08-18

Form 4: HERSHBERG ROBERT sold ADPT

HERSHBERG ROBERT (Director at Adaptive Biotechnologies Corp) reported an open-market sale of 30,664 shares of ADPT at an average $24.40, roughly $748,208, in a Form 4 filed 2026-08-20.

At post $25.44Now $28.35+11.4% since postedas of Oct 2, 4:30 PM ET
1d+2.2%
3d+2.2%
1w+3.9%
1m+12.5%
3m—
6m—
1y—
View filing on SEC.gov →
$ADPTSEC Form 4bearish
Sold 600,000 @ $24.80 avg · $14,882,166 · 2026-08-17

Form 4: ROBINS CHAD M sold ADPT

ROBINS CHAD M (CEO and Chairman at Adaptive Biotechnologies Corp) reported an open-market sale of 600,000 shares of ADPT at an average $24.80, roughly $14,882,166, in a Form 4 filed 2026-08-19.

At post $25.49Now $28.35+11.2% since postedas of Oct 2, 4:30 PM ET
1d-0.2%
3d+2.0%
1w+2.6%
1m+12.2%
3m—
6m—
1y—
View filing on SEC.gov →
$ADPTSEC Form 4bearish
Sold 124,690 @ $25.15 avg · $3,135,850 · 2026-08-17

Form 4: NEUPERT PETER M sold ADPT

NEUPERT PETER M (Director at Adaptive Biotechnologies Corp) reported an open-market sale of 124,690 shares of ADPT at an average $25.15, roughly $3,135,850, in a Form 4 filed 2026-08-19.

At post $25.49Now $28.35+11.2% since postedas of Oct 2, 4:30 PM ET
1d-0.2%
3d+2.0%
1w+2.6%
1m+12.2%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.